Showing 1 - 10 of 39
to India's new TRIPS-compliant intellectual property regime and other rules aimed at enhancing the industry's credibility …
Persistent link: https://www.econbiz.de/10010856422
Since the mid-twentieth century, the national objective of India and Brazil has been to develop industrial capabilities …. However, over fifty years, India has had much more success in building indigenous capabilities in pharmaceuticals than Brazil …
Persistent link: https://www.econbiz.de/10010712130
The impact of patent protection on biomedical innovation has been a controversial issue. Although a “medical anti-commons” has been predicted due to a proliferation of patents on upstream technologies, evidence to test these concerns is only now emerging. However, most industrial surveys...
Persistent link: https://www.econbiz.de/10010712400
, several countries like India, which played an important role as producers and exporters of generic copies of brand name …
Persistent link: https://www.econbiz.de/10010856343
This paper examines how equitable, differentiated pricing can improve access to and affordability of medicines, particularly in low- and middle-income countries, and how governments and supranational agencies can create an environment that enables pharmaceutical companies to operate a...
Persistent link: https://www.econbiz.de/10010856414
The impact of patent protection on biomedical innovation has been a controversial issue. Although a "medical anti-commons" has been predicted due to a proliferation of patents on upstream technologies, evidence to test these concerns is only now emerging. However, most industrial surveys that...
Persistent link: https://www.econbiz.de/10010712264
The mixed picture of extant research on the relationship between internal and external R&D prompts us to ask such a question: under what conditions is there complementarity or substitutability between different R&D strategies? The goal of this paper is to contribute to the empirical literature...
Persistent link: https://www.econbiz.de/10010712267
Interactive learning, particularly between firms and public research organizations (PRO), nurtures the dynamics of systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by developing countries. But why this is so? Based on...
Persistent link: https://www.econbiz.de/10010712332
Using field level data collected in Nigeria in 2003-2004, this paper examines the possibilities for learning through inter-organizational interactions in the country's biotechnological system of innovation, using public research institutes as an example. The paper considers inter-organizational...
Persistent link: https://www.econbiz.de/10010712371
The focus of this paper is to find an operative definition of traditional knowledge for purposes of drug research and development. Starting out with the international debate on Art. 8(j) of the Convention on Biological Diversity, 1993 and the Agreement on Trade Related Aspects of Intellectual...
Persistent link: https://www.econbiz.de/10010712408